| Literature DB >> 32674479 |
Constantin Ciucurel1, Elena Ioana Iconaru1.
Abstract
The aim of this study was to investigate the prevalence of the clinical features of the SARS-CoV-2 infection in Romanian population through a novel online survey. The survey included categorical socio-demographic and health-related variables. A total of 1830 participants were selected for statistical data processing (a response rate of 90.9%). We determined reasonable reliability of the survey section for clinical features of SARS-CoV-2 infection (Cronbach's Alpha 0.671). Two meaningful dimensions were identified through CATPCA (Categorical Principal Component Analysis) for the survey's items. We separated two significant clusters of items, each measuring a distinct factor: the sociodemographic characteristics linked to social distancing and the relevant clinical features of SARS-CoV-2 infection. Next, a two-step cluster analysis helped to classify the sample group taking into consideration the similarity of subjects. The clustering revealed a three-cluster solution, with significant differences between clusters and allowed the cluster detection of a group of individuals, possibly more affected by the infection with the SARS-CoV-2 virus. Through binomial logistic regression analysis, we identified a statistically significant prediction model for the presumptive diagnostic of some relevant clinical features of SARS-CoV-2 infection. Our study validated a cost-effective model for rapid assessment of the health status of subjects, adapted to the context of SARS-CoV-2 pandemic.Entities:
Keywords: COVID-19; Romanian population; online survey; prevalence study
Mesh:
Year: 2020 PMID: 32674479 PMCID: PMC7400248 DOI: 10.3390/ijerph17145082
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Summary of the sociodemographic characteristics of study participants (N = 1830).
| Item Code | Variable | Frequency | Percent |
|---|---|---|---|
| s1 | Age | ||
| 4–17 years | 49 | 2.7 | |
| 18–50 years | 1567 | 85.6 | |
| 51–64 years | 180 | 9.8 | |
| 65–90 years | 34 | 1.9 | |
| s2 | Sex | ||
| Male | 494 | 27 | |
| Female | 1336 | 73 | |
| s3 | Domicile (42 districts) | ||
| District 3 (Arges) | 1144 | 62.5 | |
| District 42 (Bucharest) | 152 | 8.3 | |
| Rest of districts | 534 | 29.2 | |
| s4 | Type of current residence | ||
| Urban | 1303 | 71.2 | |
| Rural | 527 | 28.8 | |
| s5 | Type of housing | ||
| Individual building | 966 | 52.8 | |
| Collective building | 864 | 47.2 | |
| s6 | Social status | ||
| Toddler/pre-schooler | 3 | 0.2 | |
| Pupil/Student | 583 | 31.8 | |
| Employee | 1033 | 56.4 | |
| Freelancer | 95 | 5.2 | |
| Unemployed | 17 | 0.9 | |
| Retired | 54 | 3 | |
| Housewife/househusband | 45 | 2.5 | |
| s7 | Travel abroad in the last month | ||
| Yes | 55 | 3 | |
| No | 1775 | 97 | |
| s8 | Contact with a confirmed SARS-CoV-2 case | ||
| Yes | 6 | 0.3 | |
| No | 1294 | 70.7 | |
| I don’t know | 530 | 29 | |
| s9 | Current situation related to the social distancing imposed by law | ||
| Quarantine | 69 | 3.8 | |
| Self-insulated | 831 | 45.4 | |
| Hospitalized | 1 | 0.1 | |
| Confined at home | 417 | 22.8 | |
| In the workplace | 253 | 13.8 | |
| Another situation | 259 | 14.1 | |
| s10 | Average number of contacts with people in the last two weeks | ||
| None | 165 | 9 | |
| 1–5 people | 1246 | 68.1 | |
| 6–10 people | 197 | 10.8 | |
| More than 10 people | 222 | 12. |
Summary of the health status characteristics of study participants (N = 1830).
| Item Code | Variable | Frequency | Percent |
|---|---|---|---|
| h1 | Qualitative self-assessment of the health status | ||
| Excellent | 363 | 19.8 | |
| Very good | 821 | 44.9 | |
| Good | 560 | 30.6 | |
| Satisfying | 75 | 4.1 | |
| Weak | 11 | 0.6 | |
| h2 | Testing for SARS-CoV-2 virus | ||
| Tested positive | 0 | 0 | |
| Tested negative | 8 | 0.4 | |
| Non-tested | 1822 | 99.6 | |
| h3 | Maximum level of physical activity achieved in the last two weeks | ||
| Very easy | 438 | 23.9 | |
| Mild | 462 | 25.3 | |
| Moderate | 745 | 40.7 | |
| Vigorous | 142 | 7.8 | |
| Very heavy | 22 | 1.2 | |
| Maximal | 21 | 1.1 | |
| h4 | Smoking | ||
| Yes | 510 | 27.9 | |
| No | 1320 | 72.1 | |
| h5 | Pathological personal history 1—chronic cardiovascular diseases | ||
| Yes | 112 | 6.1 | |
| No | 1718 | 93.9 | |
| Pathological personal history 2—chronic respiratory diseases | |||
| Yes | 56 | 3.1 | |
| No | 1774 | 96.9 | |
| Pathological personal history 3—chronic neurological diseases | |||
| Yes | 19 | 1 | |
| No | 1811 | 99 | |
| Pathological personal history 4—chronic renal diseases | |||
| Yes | 26 | 1.4 | |
| No | 1804 | 98.6 | |
| Pathological personal history 5—chronic rheumatic diseases | |||
| Yes | 87 | 4.8 | |
| No | 1743 | 95.2 | |
| Pathological personal history 6—diabetes mellitus | |||
| Yes | 22 | 1.2 | |
| No | 1808 | 98.8 | |
| Pathological personal history 7—oncological diseases | |||
| Yes | 12 | 0.7 | |
| No | 1818 | 99.3 | |
| Pathological personal history 8—others | |||
| Yes | 97 | 5.3 | |
| No | 1733 | 94.7 | |
| Pathological personal history 9—none | |||
| Without chronic diseases | 1484 | 81.1 | |
| With chronic diseases | 346 | 18.9 | |
| h6 | Influenza or acute respiratory infections in the last 6 months | ||
| Yes | 457 | 25 | |
| No | 1373 | 75 | |
| h7 | Influenza vaccination in the last 6 months | ||
| Yes | 150 | 8.2 | |
| No | 1680 | 91.8 | |
| h8 | Clinical feature 1—fever in the last 14 days | ||
| Yes | 21 | 1.1 | |
| No | 1809 | 98.9 | |
| h9 | Clinical feature 2—maximum body temperature measured in the last 14 days | ||
| 36.5 °C | 684 | 37.4 | |
| 37 °C | 186 | 10.2 | |
| 37.5 °C | 40 | 2.2 | |
| 38 °C | 7 | 0.4 | |
| 38.5 °C | 6 | 0.3 | |
| Non-measured | 907 | 49.5 | |
| h10 | Clinical feature 3—chills and/or increased perspiration in the last 14 days | ||
| Yes | 61 | 3.3 | |
| No | 1769 | 96.7 | |
| h11 | Clinical feature 4—increased fatigue in the last 14 days | ||
| Yes | 161 | 8,8 | |
| No | 1669 | 91.2 | |
| h12 | Clinical feature 5—episodes of persistent dry or productive cough in the last 14 days | ||
| Yes | 154 | 8.4 | |
| No | 1676 | 91.6 | |
| h13 | Clinical feature 6—sore throat or dry throat sensation in the last 14 days | ||
| Yes | 355 | 19.4 | |
| No | 1475 | 80.6 | |
| h14 | Clinical feature 7—chest pain or chest pressure sensation in the last 14 days | ||
| Yes | 99 | 5.4 | |
| No | 1731 | 94.6 | |
| h15 | Clinical feature 8—dyspnoea (breathing difficulty), suffocation and/or shortness of breath in the last 14 days | ||
| Yes | 82 | 4.5 | |
| No | 1748 | 95.5 | |
| h16 | Clinical feature 9—headache in the last 14 days | ||
| Yes | 606 | 33.1 | |
| No | 1224 | 66.9 | |
| h17 | Clinical feature 10—muscle and/or joint pain in the last 14 days | ||
| Yes | 265 | 14.5 | |
| No | 1565 | 85.5 | |
| h18 | Clinical feature 11—nasal congestion/leakage of nasal secretions in the last 14 days | ||
| Yes | 381 | 20.8 | |
| No | 1449 | 79.2 | |
| h19 | Clinical feature 12—diarrhoea, nausea, loss of appetite and/or vomiting in the last 14 days | ||
| Yes | 93 | 5.1 | |
| No | 1737 | 94.9 | |
| h20 | Clinical feature 13—loss of taste and/or odour in the last 14 days | ||
| Yes | 14 | 0.8 | |
| No | 1816 | 99.2 | |
| h21 | Face mask wearing outside the home in the last 14 days | ||
| Always | 852 | 46.6 | |
| Occasionally | 566 | 30.9 | |
| Never | 412 | 22.5 | |
| h22 | Anxiety level in the context of the pandemic with SARS-CoV-2 | ||
| Not anxious | 350 | 19.1 | |
| Mild anxious | 747 | 40.8 | |
| Moderately anxious | 563 | 30.8 | |
| Very anxious | 133 | 7.3 | |
| Extremely anxious | 37 | 2 |
Multiple response analysis, frequencies and percent of cases.
| Responses | Percent of Cases | |||
|---|---|---|---|---|
|
| Percent | |||
| Items a | h8 | 21 | 0.9% | 2.1% |
| h10 | 61 | 2.7% | 6.0% | |
| h11 | 161 | 7.0% | 15.8% | |
| h12 | 154 | 6.7% | 15.2% | |
| h13 | 355 | 15.5% | 34.9% | |
| h14 | 99 | 4.3% | 9.7% | |
| h15 | 82 | 3.6% | 8.1% | |
| h16 | 606 | 26.4% | 59.6% | |
| h17 | 265 | 11.6% | 26.1% | |
| h18 | 381 | 16.6% | 37.5% | |
| h19 | 93 | 4.1% | 9.2% | |
| h20 | 14 | 0.6% | 1.4% | |
| Total | 2292 | 100.0% | 225.6% | |
a Dichotomy group tabulated at value 1 (answer yes)
Inter-item correlation matrix (clinical features of SARS-CoV-2 infection).
| h8 | h10 | h11 | h12 | h13 | h14 | h15 | h16 | h17 | h18 | h19 | h20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| h8 | 1.000 | |||||||||||
| h10 | 0.237 | 1.000 | ||||||||||
| h11 | 0.093 | 0.265 | 1.000 | |||||||||
| h12 | 0.078 | 0.163 | 0.191 | 1.000 | ||||||||
| h13 | 0.103 | 0.186 | 0.218 | 0.269 | 1.000 | |||||||
| h14 | 0.065 | 0.144 | 0.190 | 0.154 | 0.176 | 1.000 | ||||||
| h15 | 0.125 | 0.122 | 0.231 | 0.248 | 0.174 | 0.357 | 1.000 | |||||
| h16 | 0.077 | 0.141 | 0.212 | 0.130 | 0.254 | 0.155 | 0.117 | 1.000 | ||||
| h17 | 0.072 | 0.174 | 0.327 | 0.155 | 0.195 | 0.149 | 0.129 | 0.212 | 1.000 | |||
| h18 | 0.058 | 0.122 | 0.135 | 0.252 | 0.232 | 0.109 | 0.091 | 0.223 | 0.118 | 1.000 | ||
| h19 | 0.092 | 0.096 | 0.165 | 0.073 | 0.144 | 0.154 | 0.106 | 0.154 | 0.159 | 0.151 | 1.000 | |
| h20 | −0.009 | 0.089 | 0.083 | 0.109 | 0.084 | 0.034 | 0.042 | 0.005 | 0.071 | 0.109 | 0.065 | 1.000 |
Model summary for CATPCA.
| Dimension | Cronbach’s Alpha | Variance Accounted For | ||
|---|---|---|---|---|
| Total (Eigenvalue) | Inertia | % of Variance | ||
| 1 | 0.701 | 2.937 | 0.173 | 17.277 |
| 2 | 0.638 | 2.501 | 0.147 | 14.710 |
| Total | 5.438 | 0.320 | ||
| Mean | 0.672 a | 2.719 | 0.160 | 15.993 |
a Mean Cronbach’s Alpha is based on the mean eigenvalue.
Discrimination measures for CATPCA.
| Dimension | Mean | ||
|---|---|---|---|
| 1 | 2 | ||
| s1 | 0.171 | 0.677 | 0.424 |
| s3 | 0.071 | 0.175 | 0.123 |
| s6 | 0.075 | 0.624 | 0.350 |
| s8 | 0.134 | 0.117 | 0.125 |
| s9 | 0.032 | 0.373 | 0.203 |
| s10 | 0.056 | 0.202 | 0.129 |
| h1 | 0.239 | 0.029 | 0.134 |
| h8 | 0.112 | 0.029 | 0.070 |
| h9 | 0.116 | 0.106 | 0.111 |
| h10 | 0.255 | 0.009 | 0.132 |
| h11 | 0.310 | 0.030 | 0.170 |
| h12 | 0.230 | 0.012 | 0.121 |
| h13 | 0.258 | 0.009 | 0.133 |
| h14 | 0.221 | 0.007 | 0.114 |
| h15 | 0.240 | 0.017 | 0.128 |
| h16 | 0.178 | 0.055 | 0.116 |
| h17 | 0.239 | 0.032 | 0.135 |
| Active Total | 2.937 | 2.501 | 2.719 |
| % of Variance | 17.277 | 14.710 | 15.993 |
Figure 1Categorical principal component analysis (CATPCA) biplot—component loadings of the most explanatory variables. Note: items—s1, s3, s6, s8, s9, s10, h1, h8, h9, h10, h11, h12, h13, h14, h15, h16, h17.
Characteristics of the three clusters identified by two-step clustering with variable selection based on CATPCA.
| Item Code | Variable | Cluster 1 | Cluster 2 | Cluster 3 | |
|---|---|---|---|---|---|
| s6 | Social status (%) | ||||
| Toddler/pre-schooler | 0.6% | 0 | 0 | ||
| Pupil/Student | 81.5% | 29.6% | 0 | ||
| Employee | 14.5% | 58.2% | 83.6% | ||
| Freelance | 0 | 6.1% | 7.9% | ||
| Unemployed | 0.6% | 0.8% | 1.2% | ||
| Retired | 0 | 2.1% | 5.7% | ||
| Housewife/househusband | 2.9% | 3.2% | 1.5% | ||
| h13 | Clinical feature 6—sore throat or dry throat sensation in the last 14 days (%) | ||||
| Yes | 0 | 57.4% | 0 | ||
| No | 100% | 42.6% | 100% | ||
| s1 | Age (mean ± SD, years) | 22.77 ± 6.45 | 33.38 ± 12.84 | 41.01 ± 11.59 | |
| h17 | Clinical feature 10—muscle and/or joint pain in the last 14 days (%) | ||||
| Yes | 1.2% | 39.3% | 2.2% | ||
| No | 98.8% | 60.7% | 97.8% | ||
| h11 | Clinical feature 4—increased fatigue in the last 14 days (%) | ||||
| Yes | 0.2% | 25.5% | 0.3% | ||
| No | 99.8% | 74.5% | 99.7% | ||
| h12 | Clinical feature 5—episodes of persistent dry or productive cough in the last 14 days (%) | ||||
| Yes | 1% | 23.1% | 0.8% | ||
| No | 99% | 76.9% | 99.2% | ||
| s9 | Current situation related to the social distancing imposed by law | ||||
| Quarantine | 7.7% | 4.2% | 0.7% | ||
| Self-insulated | 50.9% | 48% | 39.4% | ||
| Hospitalized | 0.2% | 0 | 0 | ||
| Confined at home | 34.8% | 20.8% | 16.2% | ||
| In the workplace | 0.6% | 16.3% | 20.7% | ||
| Another situation | 5.7% | 10.7% | 22.9% | ||
| h14 | Clinical feature 7—chest pain or chest pressure sensation in the last 14 days (%) | ||||
| Yes | 1.2% | 1.4% | 0.1% | ||
| No | 98.8% | 85.1% | 99.9% | ||
| h15 | Clinical feature 8—dyspnoea (breathing difficulty), suffocation and/or shortness of breath in the last 14 days (%) | ||||
| Yes | 0.4% | 12.9% | 0 | ||
| No | 99.6% | 87.1% | 100% | ||
| h1 | Qualitative self-assessment of the health status (%) | ||||
| Excellent | 32% | 10.8% | 19.3% | ||
| Very good | 51.1% | 38.6% | 46% | ||
| Good | 16.5% | 41% | 31.2% | ||
| Satisfying | 0.2% | 8.4% | 3.1% | ||
| Weak | 0.2% | 1.1% | 0.4% | ||
| h10 | Clinical feature 3—chills and/or increased perspiration in the last 14 days (%) | ||||
| Yes | 0% | 9.9% | 0 | ||
| No | 100% | 90.1% | 100% |
a Pearson’s Chi-square test. b One-way ANOVA.
Outputs of binomial logistic regression analysis (N = 1830).
| Independent Variable | Omnibus Test of Model Coefficients | Model Summary | Regression Coefficients and Significance Level | |||||
|---|---|---|---|---|---|---|---|---|
| Chi-Square | Nagelkerke R Square | Predictor | B | OR = Exp(B) | 95% CI for OR | |||
| h10 | 37.575 | 0.001 | 0.080 | h6 | 1.188 | 3.281 | 1.942–5.542 | 0.001 |
| h11 | 52.059 | 0.001 | 0.062 | h4 | 0.573 | 1.774 | 1.254–2.509 | 0.001 |
| h5 * | 0.724 | 2.062 | 1.376–3.091 | 0.001 | ||||
| h6 | 0.791 | 2.205 | 1.571–3.095 | 0.001 | ||||
| h21 (1) | −0.549 | 0.578 | 0.382–0.873 | 0.009 | ||||
| h12 | 118.563 | 0.001 | 0.143 | s5 | −0.434 | 0.648 | 0.428–0.982 | 0.041 |
| h4 | 0.662 | 1.938 | 1.348–2.786 | 0.001 | ||||
| h5 * | 0.706 | 2.026 | 1.343–3.058 | 0.001 | ||||
| h6 | 1.554 | 4.729 | 3.341–6.693 | 0.001 | ||||
| h13 | 43.370 | 0.001 | 0.037 | h6 | 0.722 | 2.059 | 1.602–2.646 | 0.001 |
| h14 | 36.785 | 0.001 | 0.058 | h4 | 0.842 | 2.322 | 1.522–3.543 | 0.001 |
| h5 * | 0.621 | 1.860 | 1.126–3.072 | 0.015 | ||||
| h6 | 0.574 | 1.776 | 1.156–2.728 | 0.009 | ||||
| h21 (1) | −0.688 | 0.502 | 0.298–0.847 | 0.010 | ||||
| h15 | 62.828 | 0.001 | 0.110 | h4 | 0.690 | 1.994 | 1.238–3.212 | 0.005 |
| h5 * | 1.334 | 3.796 | 2.271–6.343 | 0.001 | ||||
| h6 | 0.954 | 2.596 | 1.640–4.109 | 0.001 | ||||
| h21 (1) | −0.995 | 0.370 | 0.205–0.666 | 0.001 | ||||
| h21 (2) | −0.709 | 0.492 | 0.282–0.859 | 0.013 | ||||
| h16 | 94.766 | 0.001 | 0.070 | s1 | 0.027 | 1.028 | 1.019–1.037 | 0.001 |
| s2 | −0.384 | 0.681 | 0.538–0.862 | 0.001 | ||||
| h4 | 0.404 | 1.498 | 1.203–1.866 | 0.001 | ||||
| h5 * | 0.299 | 1.348 | 1.021–1.780 | 0.035 | ||||
| h6 | 0.424 | 1.528 | 1.218–1.915 | 0.001 | ||||
| h17 | 58.030 | 0.001 | 0.055 | h4 | 0.429 | 1.536 | 1.154–2.043 | 0.003 |
| h5 * | 0.731 | 2.078 | 1.499–2.882 | 0.001 | ||||
| h6 | 0.612 | 1.844 | 1.392–2.444 | 0.001 | ||||
| h18 | 50.597 | 0.001 | 0.043 | s1 | 0.11 | 1.011 | 1.001–1.021 | 0.028 |
| h4 | 0.294 | 1.342 | 1.045–1.724 | 0.021 | ||||
| h6 | 0.601 | 1.824 | 1.423–2.336 | 0.001 | ||||
| h21 (1) | −0.433 | 0.649 | 0.484–0.869 | 0.004 | ||||
| h21 (2) | −0.399 | 0.712 | 0.544–0.931 | 0.013 | ||||
| h19 | 37.646 | 0.001 | 0.062 | s1 | 0.040 | 1.041 | 1.021–1.062 | 0.001 |
| s7 | 1.020 | 2.772 | 1.126–6.823 | 0.027 | ||||
| h5 * | 0.703 | 2.020 | 1.193–3.419 | 0.009 | ||||
| h6 | 0.721 | 2.057 | 1.325–3.192 | 0.001 | ||||
Note: * subitem h5 (Pathological personal history 9—none); OR—Odds Ratio; p—significance level; for all items, the last answer represents the reference category; (1): always wearing face mask; (2): occasionally wearing face mask